The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: Analysis in multiple sclerosis and bacterial meningitis

Journal of Immunology

Volumn 160, Issue 7, 1998, Pages 3543-3554

  Gasque, Philippe ^a   Singhrao, Sim K ^a   Neal, Jim W ^a   Wang, Piao ^b   Sayah, Sakina ^b   Fontaine, Marc ^b   Morgan, B Paul ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3A;

ARTICLE; BACTERIAL MENINGITIS; BONE MARROW CELL; COMPLEMENT ACTIVATION; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER;

ADULT; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ASTROCYTES; BRAIN; CELL DIFFERENTIATION; CELL LINE; CELL MEMBRANE; COMPLEMENT C3A; FETUS; HUMANS; IMMUNE SERA; MACROPHAGE-1 ANTIGEN; MENINGITIS, BACTERIAL; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; MONOCYTES; MULTIPLE SCLEROSIS; NEUTROPHILS; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0032055221     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Morgan, B. P. 1990. Complement: Clinical Aspects and Relevance to Disease. Academic Press, London.
2. Frank, M. M., and L. F. Fries. 1991. The role of complement in inflammation and phagocytosis. Immunol. Today 12:322.
3. Wetsel, R. A. 1995. Structure, function and cellular expression of complement anaphylatoxin receptors. Curr. Opin. Immunol. 7:48.
4. Morgan, E. L. 1993. Complement C5a and immunoregulation. In Complement Today. Complement Profiles Series. Vol. 1. J. M. Cruse and R. E. Lewis, eds. Karger, Basel, p. 56.
5. Buchner, R. R., T. E. Hugli, J. A. Ember, and E. L. Morgan. 1995. Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. J. Immunol. 155:308.
6. Foreman, K. E., A. A. Vaporciyan, B. K. Bonish, M. L. Jones, K. J. Johnson, M. M. Glowsky, S. M. Eddy, and P. A. Ward. 1994. C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94:1147.
7. McCoy, R., D. L. Haviland, E. P. Molmenti, T. Ziambaras, R. A. Wetsel, and D. H. Perlmutter. 1995. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J. Exp. Med. 182:207.
8. Reed, S. L., J. A. Ember, D. S. Herdman, R. G. DiScipio, T. E. Hugh, and I. Gigli. 1995. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a. J. Immunol. 155:266.
9. Gerard, N. P., and Gerard, C. 1991. The chemotactic receptor for human C5a anaphylatoxin. Nature 349:614.
10. Morgan, E. L., J. A. Ember, S. D. Sanderson, W. Scholz, R. Buchner, R. D. Ye, and T. E. Hugli. 1993. Anti-C5aR antibodies: characterization of neutralizing antibodies specific for a peptide, C5aR (9-29), derived from the predicted amino-terminal sequence of the human C5a receptor. J. Immunol. 151:377.
11. 2-terminal domain. J. Immunol. 151:3785.
12. Köhl, J., and B. Bitter-Suermann. 1993. Anaphylatoxins. In Complement in Health and Disease. K. Whaley, M. Loos, and J. M. Weiler, eds. Kluwer Academic Publishers, Hingham, MA, pp. 299-324.
13. Haviland, D. L., R. L. McCoy, W. T. Whitehead, H. Akama, E. P. Molmenti, A. Brown, J. C. Haviland, W. C. Parks, D. H. Perlmutter, and R. A. Wetsel. 1995. Demonstration of C5aR on non-myeloid cells of the liver and lung. J. Immunol. 154:1861.
14. Casque, P., P. Chan, M. Fontaine, A. Ischenko, M. Lamacz, O. Götze, and B. P. Morgan. 1995. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155:4882.
15. Fureder, W., H. Agis, M. Willheim, H. C. Bankl, U. Maier, K. Kishi, M. R. Muller, K. Czerwenka, T. Radazkiewicz, J. H. Butterfield, G. W. Klappacher, W. R. Sperr, M. Oppermann, K. Lechner, and P. Valent. 1995. Differential expression of complement receptors on human basophils and mast cells: evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J. Immunol. 155:3152.
16. Gasque, P., S. K. Singhrao, J. W. Neal, O. Gotze, and B. P. Morgan. 1997. Expression of the receptor for complement C5a (CD88) is upregulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 150:31.
17. Fukuoka, Y., and T. E. Hugli. 1988. Demonstration of a specific C3a receptor on guinea pig platelets. J. Immunol. 140:3496.
18. 125I-C3a binding. Biochemistry 31:11274.
19. Takabayashi, T., E. Vannier, B. D. Clark, N. H. Margolis, C. A. Dinarello, J. F. Burke, and J. A. Gelfand. 1996. A new biologic role for C3a and C3adesarg: regulation of TNF-α and IL-1β synthesis. J. Immunol. 156:3455.
20. Daffern, P. J., P. H. Pfeifer, J. A. Ember, and T. E. Hugli. 1995. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J. Exp. Med. 181:211.
21. Legler, D. F., M. Loetscher, S. A. Jones, C. A. Dahinden, M. Arock, and B. Moser. 1996. Expression of high-and low-affinity receptors for C3a on the human mast cell line, HMC-1. Eur. J. Immunol. 26:753.
22. Nilsson, G., M. Johnell, C. H. Hammer, H. L. Tiffany, K. Nilsson, D. D. Metcalfe. A. Siegbahn, and P. Murphy. 1996. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J. Immunol. 157:1693.
23. Baldo, A., A. D. Sniderman, S. St-Luce, R. K. Avramoglu, M. Maslowska, B. Hoang, J. C. Monge, A. Bell, S. Mulay, and K. Cianflone. 1993. The adipsinacylation stimulating protein system and regulation of intracellular triglyceride synthesis. J. Clin. Invest. 92:1543.
24. Roglic, A., E. R. Prossnitz, S. L. Cavanagh, Z. Pan, A. Zou, R. D. Ye. 1996. cDNA cloning of a novel G protein-coupled extracellular loop structure. Biochim. Biophys. Acta 1305:39.
25. Ames, R. S., Y. Li, H. M. Sarau, P. Nuthulaganti, J. J. Foley, C. Ellis, Z. Zheng, K. Su, A. J. Jurewicz, R. P. Hertzberg, D. J. Bergsma, and C. Kumar. 1996. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J. Biol. Chem. 271:20231.
26. Crass, T., U. Faffetseder, U. Martin, M. Grove, A. Klos, J. Köhl, and W. Bautsch. 1996. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells. Eur. J. Immunol. 26:1944.
27. Morgan, B. P., and P. Gasque. 1996. Expression of complement in the brain: role in health and disease. Immunol. Today 17:461.
28. Armstrong, R. C., L. Harvath, and M. E. Dubois-Dalcq. 1990. Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules. J. Neurosci. Res. 27:400.
29. i signalling in mouse microglia. J. Neurosci. 17:615.
30. Armstrong, R. C., H. H. Dorn, C. V. Kufta, E. Friedman, and M. E. Dubois-Dalcq. 1992. Pre-oligodendrocytes from adult human CNS. J. Neurosci. 12:1538.
31. Harris, C. L., K. S. Kan, G. T. Stevenson, and B. P. Morgan. 1997. Tumour cell killing using chemically engineered antibody constructs specific for tumour cells and the complement inhibitor CD59. Immunology 107:364.
32. Singhrao, S. K., J. W. Neal, P. Gasque, B. P. Morgan, and G. R. Newman. 1996. Role of complement in the aetiology of Pick's disease? J. Neuropathol. Exp. Neurol. 55:578.
33. Gasque, P., P. Chan, C. Mauger, M. T. Schouft, S. Singhrao, M. P. Dierich, B. P. Morgan, and M. Fontaine. 1996. Identification and characterization of complement C3 receptors on human astrocytes. J. Immunol. 156:2247.
34. Burg, M., U. Martin, D. Bock, C. Rheinheimer, J. Kohl, W. Bautsch, and A. Klos. 1996. Differential regulation of the C3a and C5a receptors (CD88) by IFN-γ and PMA in U937 cells and related myeloblastic cell lines. J. Immunol. 157:5574.
35. Burg, M., U. Martin, C. Rheinheimer, J. Kohl, W. Bautsch, E. C. Bottger, and A. Klos. 1995. IFN-γ upregulates the human C5a receptor (CD88) in myeloblastic U937 cells and related cell lines. J. Immunol. 155:4419.
36. Gasque, P., A. Ischenko, J. Legoedec, C. Mauger, M. T. Schouft, and M. Fontaine. 1993. Expression of the complement classical pathway by human glioma in culture. J. Biol. Chem. 268:25068.
37. Gasque, P., P. Chan, C. Mauger, M. T. Schouft, S. Singhrao, M. P. Dierich, B. P. Morgan, and M. Fontaine. 1996. Identification and characterization of complement C3 receptors on human astrocytes. J. Immunol. 156:2247.
38. Shrikant, P., and E. N. Benveniste. 1996. The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation. J. Immunol. 157:1819.
39. Ernst, J. D., K. T. Hartiala, I. M. Goldstein, and M. A. Sande. 1984. Complement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis. Infect. Immun. 46:81.
40. Yao, J., L. Harvath, D. L. Gilbert, and C. A. Colton. 1990. Chemotaxis by a CNS macrophage, the microglia. J. Neurosci. Res. 27:30.
41. Hugli, T. E. 1983. Structure and function of anaphylatoxins. Springer Semin. Immunopharmacol. 6:173.
42. Gerard, C., L. Bao, O. Orozco, M. Pearson, D. Kunz, and N. P. Gerard. 1992. Structural diversity in the extracellular faces of peptidergic G-protein-coupled receptors: molecular cloning of the mouse C5a anaphylatoxin receptor. J. Immunol. 149:2600.
43. Sayah, S., C. Patte, P. Gasque, P. Chan, A. Ischenko, H. Vaudry, and M. Fontaine. 1997. Characterization of rat C5a anaphylatoxin receptor (C5aR). partial sequencing of rat C5aR cDNA and study of its expression in rat brain. Mol. Brain Res. 48:215
44. Tornetta, M. A. J. J. Foley, H. M. Sarau, and R. S. Ames. 1997. The mouse anaphylatoxin C3a receptor: molecular cloning, genomic organization and functional expression. J. Immunol. 158:5277.